Alpha Sense BI

FEBRUARY 6, 2024

This research often includes assessing the financial performance, market potential, competitive landscape, regulatory environment and growth potential of target healthcare companies, drugs, medical technologies, treatments and more.

Research 98

Research Primary Research Due Diligence Competitive Positioning 98

Alpha Sense BI

FEBRUARY 3, 2023

ESG investing –it’s a market trend that’s gained traction with ethical investors, multi-billion dollar companies, mammoth private equity firms, and recently, the Securities and Exchange Commission (SEC) and International Sustainability Standards Board ( ISSB ). timber, natural pharmaceuticals) and services (i.e.,

Finance 98

Finance Due Diligence Banking Pharmaceutical 98

Alpha Sense BI

DECEMBER 12, 2023

These intangible factors indicate that even the most exhaustive due diligence processes can still leave gaps in the M&A research process. Comprehensive Due Diligence Thorough due diligence on a target company is undeniably the cornerstone of successful M&A.

Due Diligence 52

Due Diligence Primary Research Competitive Intelligence Market Intelligence 52

Alpha Sense BI

MAY 28, 2024

Below, we explore the factors constraining venture capital funding into the first half of the year, and the ways investors can leverage crucial market intelligence to gain a competitive advantage in the shifting landscape. These prospects are more likely to secure financing ahead of their more risky, underdeveloped counterparts.

Capital 69

Capital Startups Biotech Due Diligence 69

Alpha Sense BI

APRIL 12, 2024

Generally, expert calls provide investment researchers with the operator’s perspective, which is critical to understanding competitive moats and enhancing data-driven research with soft data. You think, ‘I have competitively a better methodology, a better framework, and you think the world will go on it.’ It’s one of those things.

Primary Research 52

Primary Research Advantage Advantage Research 52

Alpha Sense BI

DECEMBER 15, 2023

Massive Data Analysis It’s clear that the pharmaceutical industry is increasingly in need of handling and interpreting expansive datasets efficiently and accurately. Adapting to these changes positions biopharma brands advantageously in a competitive landscape, ensuring they remain relevant and visible.

Pharmaceutical 52

Pharmaceutical Algorithm Predictive Analytics Research 52